|
|
|
This is the preliminary program for the 2009 Joint Statistical
Meetings in Washington, DC.
|
|
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2009 Program page |
= Applied Session,
= Theme Session,
= Presenter
123
|
Mon, 8/3/09, 8:30 AM - 10:20 AM | CC-150A |
| Issues in Phase II and Dose-Ranging Trials - Contributed - Papers | ||
|
Biopharmaceutical Section, Section on Bayesian Statistical Science |
||
| Chair(s): Yu-Ling Chang, FDA | ||
| 8:35 AM |
Brick Tunnel Randomization: A Way to Accommodate a Problematic Allocation Ratio in Adaptive Design Dose-Finding Studies —  Olga M. Kuznetsova, Merck & Co., Inc.; Yevgen Tymofyeyev, Merck & Co., Inc.
|
|
| 8:50 AM |
A Comparison of False Negative Rates from Dose-Response Relationship Test Only with Dose-Response Relationship Test Along with a Pairwise Test — Mohammad Rahman, FDA
|
|
| 9:05 AM |
Convergence of Best Intention Adaptive Designs in Dose-Finding Experiments — Yuehui Wu, GlaxoSmithKline; Valerii V. Fedorov, GlaxoSmithKline
|
|
| 9:20 AM |
Modeling Heterogeneity and Its Effect on Design Parameters in Phase II Clinical Trials — Christopher N. Barnes, University of Louisville; Shesh N. Rai, University of Louisville
|
|
| 9:35 AM |
Consonant Closed Test Procedures in Dose-Response Study — Bushi Wang, University of California, Riverside; Xinping Cui, University of California, Riverside
|
|
| 9:50 AM |
A Hierarchical Bayesian Approach for Controlled Phase II Cancer Trials in Heterogeneous Diseases — Lanjia Lin, Florida State University; Jyotirmoy Dey, Novartis Pharmaceuticals; Lumay Chiang, Novartis Oncology
|
|
| 10:05 AM |
An Alternative to the Peto Analysis for Two-Year Carcinogenicity Studies and to Tarone's Test for Trend on Censored Survival Data — Arthur Roth, AJR Statistical Consulting
|
|
|
JSM 2009
For information, contact jsm@amstat.org
or phone (888) 231-3473. If you have questions about the Continuing Education program,
please contact the Education Department. |